age also plays a role, with individuals under 20 having higher rates of five-year survival at 85 per cent. after the age of 20 and before the age of 54, survival rates dip to 65 per cent, with a 13 per cent survival rate being associated with people 55 and older.
glioblastoma, which accounts for roughly half of all cancerous brain tumours, is also found in higher rates in males, whereas meningioma is the most common in females at rates of five and seven out of every 100,000 people, respectively.
when examining the most common types of tumours and who they affect most, females had a higher rate of survival after diagnosis, with
60 per cent of females surviving at least five years following diagnosis. in contrast, only
six-to-seven per cent of adults of all genders will survive to that same five-year mark after being diagnosed with glioblastoma.
while no data has been found on how often a person develops brain cancer based on risk factors, there are some associated with the disease, including genetic conditions, family history, prior radiation therapy, and a weakened immune system. it’s also more likely to be diagnosed in older adults, men, and people who have experienced viral infections, such as the epstein-barr virus. obesity is also linked to a higher risk of meningioma, the most common tumour found in females.
of all brain tumours that develop, roughly 20 to 40 per cent will become metastatic.
impact of brain cancer on canadian society
brain cancer affects individuals, their families, as well as the canadian healthcare and economic systems. both direct and indirect healthcare costs are associated with brain cancer on both a personal and societal level.
in terms of the person and their family, the financial impact can be considerable. according to research, the
total cost of brain cancer in canada sits at roughly $3.2 million per year. that is split up into both direct expenses, with diagnostics and treatments accounting for 46 per cent and indirect costs such as loss of productivity accounting for 54 per cent of the total cost associated with brain cancer.